Is Bentyl (dicyclomine) a suitable treatment for smooth muscle spasms in the gastrointestinal tract?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bentyl (Dicyclomine) for Gastrointestinal Smooth Muscle Spasms

Bentyl (dicyclomine) is an effective treatment for smooth muscle spasms in the gastrointestinal tract, with the American Gastroenterological Association (AGA) suggesting its use for irritable bowel syndrome (IBS) patients based on demonstrated efficacy in relieving abdominal pain and global IBS symptoms. 1, 2

Mechanism of Action

  • Dicyclomine relieves smooth muscle spasm through a dual mechanism: a specific anticholinergic (antimuscarinic) effect at acetylcholine-receptor sites and a direct effect on smooth muscle (musculotropic) 3
  • It is approximately 1/8 the milligram potency of atropine at anticholinergic receptor sites while also antagonizing bradykinin and histamine-induced spasms 3
  • This dual mechanism makes it particularly effective for gastrointestinal smooth muscle spasms compared to pure anticholinergic agents 3

Efficacy in Gastrointestinal Disorders

  • Antispasmodics like dicyclomine provide significant global relief of IBS symptoms compared to placebo (RR, 0.67; 95% CI, 0.55–0.80) 1, 2
  • Dicyclomine demonstrates improvement in abdominal pain compared to placebo (RR, 0.74; 95% CI, 0.59–0.93) 1, 2
  • Clinical studies show dicyclomine at 40mg four times daily is superior to placebo in improving overall patient condition, decreasing abdominal pain, reducing abdominal tenderness, and improving bowel habits 4
  • Dicyclomine is one of only three antispasmodics (along with hyoscine and peppermint oil) available in the United States with demonstrated efficacy for IBS symptoms 1

Dosing and Administration

  • Standard dosing is 20mg tablets four times daily, with sustained-release 40mg formulations showing equivalent efficacy and similar side effect profiles 5
  • For IBS treatment, studies have used 40mg four times daily with significant efficacy 4
  • Peak plasma concentration is reached within 60-90 minutes after oral administration 3
  • Mean half-life of plasma elimination is approximately 1.8 hours, with a secondary phase of elimination showing a somewhat longer half-life 3

Side Effects and Precautions

  • Most common adverse events include dry mouth, dizziness, and blurred vision due to anticholinergic effects 1, 6
  • Other potential side effects include abdominal distension and syncope 6
  • Regular use in constipation-predominant conditions may be limited due to its anticholinergic effects 1, 2
  • Elderly patients are more susceptible to anticholinergic side effects 6
  • The drug can inhibit secretion of saliva and sweat, decrease gastrointestinal secretions and motility, cause drowsiness, dilate pupils, increase heart rate, and depress motor function 3

Special Considerations

  • Dicyclomine has been successfully used in other smooth muscle spasm conditions beyond IBS, including treatment of anal fissures with associated internal sphincter spasm 7
  • The AGA recommends antispasmodics like dicyclomine with a conditional recommendation based on low certainty evidence 1
  • While often recommended for postprandial symptoms in IBS, this specific indication has not been thoroughly studied in randomized controlled trials 1
  • Alternative antispasmodics with fewer anticholinergic properties (like mebeverine or alverine citrate) may be considered if anticholinergic side effects are problematic 6

Monitoring and Follow-up

  • Regular monitoring for side effects is recommended when initiating therapy 6
  • Maintaining adequate hydration may help minimize some side effects like muscle cramping 6
  • The majority of adverse effects are related to the anticholinergic activity of the drug 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clinical Application of Dicyclomine in Gastrointestinal Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Side Effects of Dicyclomine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.